Saturday 17 April 2021
Home      All news      Contact us      RSS     
channelnewsasia - 2 month ago

EU regulator says Celltrion s COVID-19 antibody drug under real-time review

Europe s drug regulator said on Wednesday it was evaluating South Korean drugmaker Celltrion s COVID-19 antibody treatment, the third such drug against the disease to go under real-time review in the region.


Latest News
Hashtags:   

regulator

 | 

Celltrion

 | 

COVID

 | 

antibody

 | 

under

 | 

review

 | 

Sources